Posted by Michael Wonder on 13 Nov 2019
Epilepsy NZ calls for halt to drug switch following deaths of three people
13 November 2019 - Epilepsy New Zealand is urging authorities to immediately halt a drug switch following the death of three people.
The state drug-buyer, PHARMAC, began in May switching 11,000 patients, most with epilepsy, to a generic form of the drug lamotrigine called Logem.
Medsafe's Centre for Adverse Reactions Monitoring has been notified of three deaths which have been referred to the coroner.
